Enanta Pharmaceuticals | ENTA - Ebit





Ebit Cambio Fecha
AbbVie USD 6.88B 156M 2026-09
Amgen USD 4.68B 65M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Incyte USD -707.47M 1.41B 2026-09
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Merck USD 7.33B 6.49B 2026-09
Neurocrine Biosciences USD 343M 123.1M 2026-09
Novartis USD 5.14B 411M 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09